Toronto-Dominion Bank »

Biomarin Pharmaceutical shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 2.0M 0.95

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Cibc Cad (CM)
Tesla Motors (TSLA)
Amazon (AMZN)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Canadian Natural Resources (CNQ)
Spdr Gold Tr Gold Shs (GLD)
Bank Of Montreal Cadcom (BMO)
Meta Platforms Cl A (META)
Tc Energy Corp (TRP)
UnitedHealth (UNH)

View all positions for Toronto-Dominion Bank

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical